Drug Shortage Report for TEVA-ONDANSETRON

Last updated on 2023-04-28 History
Report ID 142604
Drug Identification Number 02296357
Brand name ACT ONDANSETRON
Common or Proper name ONDANSETRON 8MG FC TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ONDANSETRON
Strength(s) 8MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 10UD
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-07-13
Estimated end date Unknown
Actual end date 2023-04-27
Shortage status Resolved
Updated date 2023-04-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-07-15 English Compare
v2 2021-07-15 French Compare
v3 2023-04-27 English Compare
v4 2023-04-27 French Compare
v5 2023-04-28 English Compare

Showing 1 to 5 of 5